中彙集團(0382.HK)跌幅收窄 成交額明顯放大
格隆匯1月13日丨中彙集團(0382.HK)跌幅收窄,成交額明顯放大至1.95億港元。中彙集團公吿擬以8.73港元配股5330萬股,淨籌資4.6億港元。公司認為,配售事項是公司籌集額外資本的良機,從而加強公司的資本基礎,以用於日後可能進行之收購及發展集現有和新校區,併為集團提供營運資金,而不會產生利息成本。據悉,公司2021年業績指引4.54億,同比增47%;2022年業績指引8.15億,同比增80%。有業內人士指出,2022年要達到8億元的利潤,估計是靠新的併購達到,而目前的配股籌資正是在做併購準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.